skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods of treating Parkinson's disease using viral vectors

Patent ·
OSTI ID:1332285

Methods of delivering viral vectors, particularly recombinant adeno-associated virus (rAAV) virions, to the central nervous system (CNS) using convection enhanced delivery (CED) are provided. The rAAV virions include a nucleic acid sequence encoding a therapeutic polypeptide. The methods can be used for treating CNS disorders such as for treating Parkinson's Disease.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC03-76SF00098; AC02-05CH11231
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
9,492,415
Application Number:
13/647,155
OSTI ID:
1332285
Resource Relation:
Patent File Date: 2012 Oct 08
Country of Publication:
United States
Language:
English

References (32)

Method of treating parkinson's syndrome patent April 1990
AAV transduction vectors patent August 1992
Production of recombinant adeno-associated virus vectors patent December 1992
Gene therapy patent March 1995
Ribozymes targeted to apo(a) mRNA patent February 1997
In vitro packaging of adeno-associated virus DNA patent October 1997
Convection-enhanced drug delivery patent February 1998
Method for production of neuroblasts patent April 2000
Genetically engineered cells that produce produce L. Dopa patent August 2000
AAV-mediated delivery of DNA to cells of the nervous system patent January 2001
AAV-mediated delivery of DNA to cells of the nervous system patent January 2003
Methods of treating central nervous system disorders using viral vectors patent October 2005
Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease journal March 1997
Application of Gene Therapy for Parkinson's Disease: Nonhuman Primate Experience book January 1997
Adeno-associated virus vectors journal October 1992
Ligand-targeted receptor-mediated vectors for gene delivery journal January 1998
A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes journal September 1998
Total synthesis of a human leukocyte interferon gene journal August 1981
Prospects and problems of gene therapy: an update journal October 2001
Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5 journal July 1977
Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey Brain journal March 2006
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector journal January 1999
Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy journal July 1994
Mechanism of MPTP toxicity: more answers, more questions journal January 1985
Long-term restoration of striatal l-aromatic amino acid decarboxylase activity using recombinant adeno-associated viral vector gene transfer in a rodent model of Parkinson's disease journal August 1999
Effect of ischemic cerebral volume changes on behavior journal August 1997
l-Dopa and Dopamine-Producing Gene Cassettes for Gene Therapy Approaches to Parkinson's Disease journal March 1997
Gene Therapy in the United States: A Five-Year Status Report journal September 1996
Viral Gene Delivery Selectively Restores Feeding and Prevents Lethality of Dopamine-Deficient Mice journal January 1999
Gene therapy - promises, problems and prospects journal September 1997
Adeno-associated virus vector-mediated transduction in the cat brain journal September 2003
Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System journal March 1997

Similar Records

Methods of treating Parkinson's disease using viral vectors
Patent · Tue Nov 13 00:00:00 EST 2012 · OSTI ID:1332285

Methods of treating parkinson's disease using viral vectors
Patent · Tue May 19 00:00:00 EDT 2009 · OSTI ID:1332285

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
Journal Article · Fri Aug 17 00:00:00 EDT 2018 · Neural Regeneration Research · OSTI ID:1332285